论文信息 - Protocol for a Phase 1, Open-Label, Multiple-Center, Dose-Escalation Study to Evaluate the Safety and Tolerability of ADR-001 in the Treatment of Immunoglobulin A Nephropathy - 字舞流文

Protocol for a Phase 1, Open-Label, Multiple-Center, Dose-Escalation Study to Evaluate the Safety and Tolerability of ADR-001 in the Treatment of Immunoglobulin A Nephropathy

S. Maruyama | K. Maeda | F. Kinoshita | T. Kosugi | T. Ishimoto | S. Shimizu | A. Tanaka | Y. Kuwatsuka | K. Furuhashi | Y. Nakai | Y. Saka | T. Naruse | Kumiko Fujieda | Shoji Saito | Tetsushi Mimura